
    
      Fondaparinux 1.5mg/day subcutaneously administered during post-surgery 1 to 10 days with the
      1st treatment administration performed 6 to 8 hours after the end of surgery.

      Screening visit : > 7 days before inclusion visit if THR and TKR Inclusion visit : day of
      surgery Visits with blood drawing: 3 visits scheduled during 1 to 10 days of treatment period
      Study end of treatment visit: D1 to D10 Study end visit: 1 month Â± 15 days
    
  